At 227.3x earnings with a Forward P/E of 18.6, the market is clearly looking past current distortions and pricing in a sharp normalization, yet the 3.8 PEG suggests that even on forward numbers growth is not cheap. The real red flag is the Altman Z-Score of 0.6, which signals material balance sheet stress risk, and that overwhelms the seemingly modest 1.4x book valuation. A 3.80% ROE and -5.60% operating margin confirm that profitability is currently impaired, while the dramatic compression from 227.3x to 18.6x forward earnings implies extreme earnings volatility rather than stable compounding. This is not a clean mispricing; it is a cyclical and balance-sheet-risk story being given the benefit of the doubt by equity markets.